We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/11/2020 10:28 | you can buy at 77.45p at present.... | barrywhit | |
06/11/2020 10:18 | ordinarily selling like we have now would be more impactful on the bid! or is the offer really 77p? | jusjusjus | |
06/11/2020 10:08 | hearing rapid test has been abandoned in Liverpool, lol. | thehitman1 | |
06/11/2020 09:24 | I'm afraid not all options have an exit price, but it is what it is.... | barrywhit | |
06/11/2020 09:24 | It's share options isn't it. | coley15 | |
06/11/2020 09:13 | re - "more options" Looking at it in a positive way: 1 - Happy staff making some money 2 - More money for the company because the options have an option price. | master rsi | |
06/11/2020 09:06 | but not sold straight away as per the wording of other RNS on staff options! | jusjusjus | |
06/11/2020 09:04 | What a surprise "more options" to be sold into the market.... | barrywhit | |
06/11/2020 08:44 | Operation Moonshot: rapid Covid test missed over 50% of cases in pilot Exclusive: mass-testing experts say tests should not be widely used in hospitals or care homes First published on Thu 5 Nov 2020 18.23 GMT A Covid-19 display in Liverpool where the use of the Direct RT-Lamp test has been scaled down to a small number of NHS staff, according to the government. Photograph: Christopher Furlong/Getty Images A rapid coronavirus test at the heart of Boris Johnson’s mass-testing strategy missed more than 50% of positive cases in an Operation Moonshot pilot in Greater Manchester, the Guardian can reveal. The 20-minute tests, on which the government has spent £323m for use with hospital and care home staff with no symptoms, identified only 46.7% of infections during a crucial trial in Manchester and Salford last month. This means that many of those carrying Covid-19 were wrongly told they were free of the virus, potentially allowing them to infect others...... more | master rsi | |
06/11/2020 08:35 | Storming ahead this morning | master rsi | |
06/11/2020 08:17 | Link below for those that want to keep up with LFT Tenders: | barrywhit | |
06/11/2020 08:08 | “X KING OF TAJ MAHAL” 👑 Hitman Patience patience thats all we need give it another few weeks and watch BOOM 💥 | riz000 | |
06/11/2020 07:55 | lots of clues but no confirmation.Need orders!!!. | thehitman1 | |
06/11/2020 07:21 | There were two video presentations by ODX yesterday on BRR Media, and there's two more to come at 11.00 this morning: | rivaldo | |
05/11/2020 22:51 | CIGA Healthcare Limited, news. | oapknob1 | |
05/11/2020 22:45 | The more sales the better as far as I am concerned.everyone seems to have forgotten how home use of food tech validation in china could transform omega. | upomega | |
05/11/2020 22:04 | They are made in China!!! - look closely at the box | janhar | |
05/11/2020 20:55 | Good on the government. As I posted previously why arent omega and other diagnostic companies lobbying parliament through their mps. Also omega being predominantly Scottish. Where is nicola sturgeon. No point moaning inmv. All I know is had it been english and if I had been working for them I would be lobbying my local mp. | upomega | |
05/11/2020 18:40 | Tanner Pharma (St. Albans) to supply Rapid LFT's to the Government £10 million Order.. | barrywhit | |
05/11/2020 18:13 | barrywhit we might have to endure these prices for a few more weeks BUT it will break shortly with News. Excluding NCYT as already successful of the remainder AVCT seems a lot further off regulatory approval/Genedrive is still away off has a small market cap and could bounce on news but is limited/Synairgen is a good bet but still needs to get through Phase III trials and beyond before hitting the market and then there is ODX: By a country mile and so close to the end game of home testing for both antibody and antigens / gearing up for 2 million plus units a week by April ... DYOR but this has to be the best bet going forward. Thanks for your posts always informative. | ant15 | |
05/11/2020 17:51 | Its good to see and hear Boris talking and enthusiastic about LFTs on this evenings T.V update... | barrywhit | |
05/11/2020 17:01 | Jag Grewal on twitter talking about Food Intolerance: | barrywhit | |
05/11/2020 16:53 | Interesting find Barrywhit I would suggest that ODX with or without the RTC fits Lots 2 and 4 | carlisle44 | |
05/11/2020 15:52 | looks pretty much like provision and distribution of home testing kits! | jusjusjus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions